[ Pharmaceutical Sciences Asia - ONLINE ]
E-ISSN 2586-8470
[ Journal Abbreviation: Pharm.Sci.Asia ]
Mahidol University Journal of Pharmaceutical Sciences
  FORMER NAME   "Mahidol University Journal of Pharmaceutical Sciences" Published Since 1974

 
Abstracts

DOI: 10.29090/psa.2026.04.26.11079Pharm Sci Asia 2026; 53(4), 483-495
 

In vitro and in vivo studies of the antidiabetic activities of Albizia lebbeck (L.) Benth (Fabaceae) aqueous leaf extract

Nayagam Agnel Arul John1, Gunasekaran Shobana1, Thillaivasan Prabhash2, Kumaraswamy Athesh3*

1 Department of Biochemistry, Srimad Andavan Arts and Science College (Autonomous), Affiliated to Bharathidasan University, Tiruchirappalli – 620 005, India
2 Department of Biochemistry, Bharathidasan University, Tiruchirappalli – 620 024, India
3 Division of Phytochemistry & Phytotherapeutics, School of Sciences, Bharata Mata College (Autonomous), Kochi – 682 021, India


Diabetes mellitus is a growing worldwide health issue that requires effective and safe therapeutic interventions. In recent years, plant-derived antidiabetic agents have gained a lot of interest due to their safety, efficacy and affordability. Albizia lebbeck, traditionally been used in diabetes management, lacks sufficient scientific evidence, especially with regard to its aqueous leaf extract. Therefore, the present study evaluated the antidiabetic efficacy of aqueous leaf extract of Albizia lebbeck (ALEAL) through in-vitro ?-amylase and ?-glucosidase inhibitory assays and in-vivo studies using alloxan-induced diabetic Wistar rats, at doses of 100, 250 and 500 mg/kg body weight, followed by biochemical, enzymatic, oxidative stress, and histopathological assessments. Phytochemical screening of ALEAL revealed the presence of phenols, flavonoids, tannins, alkaloids, saponins, coumarins, and terpenoids. ALEAL exhibited significant enzyme inhibitory activity against ?-amylase and ?-glucosidase, with IC50 values of 137.7 ?g/ml and 115.2 ?g/ml, respectively. Treatment of diabetic rats with ALEAL significantly reduced blood glucose levels (36.6% reduction at the highest dose) and enhanced insulin secretion. In addition, ALEAL improved lipid profile, attenuated hepatic and renal dysfunction markers, and reduced oxidative stress by decreasing malondialdehyde levels while increasing antioxidant enzymes, including GSH, SOD, CAT, GPx, and GR. Furthermore, ALEAL enhanced glucokinase activity, increased hepatic glycogen content, and suppressed glucose-6-phosphatase activity. Histopathological analysis confirmed restoration of pancreatic architecture. Collectively, these findings suggest that ALEAL exerts potent antidiabetic effects through modulation of glucose metabolism, carbohydrate-hydrolyzing enzyme inhibition, antioxidant defense, and pancreatic protection, supporting its potential as a promising natural therapeutic agent for diabetes management.


Keyword:

Antidiabetic; Alloxan; Albizia lebbeck; Oxidative stress; Pancreas




Download full paper (PDF File size: 1,437.54 KB.)





Vol.53
No.4
October-December 2026

See other volume

 


Vol.53
No.3
July-September 2026

See other volume

 


Vol.53
No.2
April-June 2026

See other volume

 


Vol.53
No.1
January-March 2026

See other volume

 
 
 

Home
Aims and Scope
Editorial Board
Publication Ethics
Instruction to Authors
Announcement
All Volumes & Issues
Submit Online
Contact us
   
Search
   
Faculty of Pharmacy Mahidol University
Mahidol University



Pharmaceutical Sciences Asia by Faculty of Pharmacy, Mahidol University, Thailand is licensed under CC BY-NC-ND 4.0

    Copyright © 2017-2026
    Faculty of Pharmacy, Mahidol University, THAILAND
 

We use Cookies

This site uses cookies to personalise your experience and analyse site traffic. By Clicking ACCEPT or continuing to browse the site you are agreeing to our use of cookies.